middle.news
Bioxyne Secures Exclusive Rights to Launch Curaleaf’s Medical Cannabis Inhaler in Australia
8:38am on Monday 3rd of November, 2025 AEDT
•
Healthcare
Read Story
Bioxyne Secures Exclusive Rights to Launch Curaleaf’s Medical Cannabis Inhaler in Australia
8:38am on Monday 3rd of November, 2025 AEDT
Key Points
Exclusive import, manufacture, and distribution agreement with Curaleaf International
Therapeutic Goods Administration and Office of Drug Control approvals secured
Launch of Que Medical Inhalation Device nationwide from November 2025
New recurring revenue stream expected to support FY26 revenue guidance of $65m-$75m
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BXN
OPEN ARTICLE